Results 101 to 110 of about 8,552 (200)

The First CRISPR-Based Therapeutic (SL_1.52) for African Swine Fever Is Effective in Swine. [PDF]

Viruses
Verma N, O'Mahony A, Mohammad R, Keiser D, Mosman CW, Holden D, Starr K, Bauer J, Bauer B, Suntisukwattana R, Atthaapa W, Tantituvanont A, Nilubol D, Gladue DP.   +13 more
europepmc   +1 more source

PREDICTABILITY OF ECONOMIC ACTIVITY USING YIELD SPREADS: THE CASE OF BRAZIL [PDF]

Benjamin M. Tabak, Mateus A. Feitosa
core  

Machine Learning for Predicting Human Drug-Induced Cardiotoxicity: A Scoping Review. [PDF]

Toxics
Han JY, Kim MJ, Kim H, Choi K, Ju S, Kim MG.   +5 more
europepmc   +1 more source

Correction to: Low‑iodine‑dose computed tomography coupled with an artificial intelligence‑based contrast‑boosting technique in children: a retrospective study on comparison with conventional‑iodine‑dose computed tomography. [PDF]

Pediatr Radiol
Shin DJ, Choi YH, Lee SB, Cho YJ, Lee S, Cheon JE.   +5 more
europepmc   +1 more source

Duration of antibacterial treatment for uncomplicated urinary tract infection in women [PDF]

, 2005
BAERHEIM, A, Christiaens, Thierry, KATCHMAN, EA, LEIBOVICI, L, MILO, G, PAUL, M   +5 more
core   +1 more source

Pharmaceutical biotechnology

Current Opinion in Biotechnology, 1995
, McCormick, , Wierenga
openaire   +4 more sources

Response to letter re: Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study: Not all BRCA mutations are equal: functional context and mutation type as co-determinants of PARP inhibitor response. [PDF]

ESMO Open
Marchetti C, Fagotti A, Fruscio R, Cassani C, Incorvaia L, Perri MT, Sassu CM, Camnasio CA, Giudice E, Minucci A, Seca M, Arbustini E, Vertechy L, De Bonis M, Boccia SM, Giannarelli D, Salutari V, Distefano M, Ferrandina MG, Nero C, Musacchio L, Russo A, Scambia G, Lorusso D.   +23 more
europepmc   +1 more source

Industrial Pharmaceutics

European Journal of Pharmaceutical Sciences, 2016
Christoph, Saal, René, Holm
openaire   +2 more sources

Response to letter re: Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study. [PDF]

ESMO Open
Marchetti C, Fagotti A, Fruscio R, Cassani C, Incorvaia L, Perri MT, Sassu CM, Camnasio CA, Giudice E, Minucci A, Seca M, Arbustini E, Vertechy L, De Bonis M, Boccia SM, Giannarelli D, Salutari V, Distefano M, Ferrandina MG, Nero C, Musacchio L, Russo A, Scambia G, Lorusso D.   +23 more
europepmc   +1 more source

Household wealth and its association with non-adherence, quality of life, anxiety and depression amongst hemodialysis patients in two centers in Cameroon. [PDF]

BMC Nephrol
Fouda HDEEM, Mouaffo FNM, Nzana VB, Tumchou P, Elimby L, Teuwafeu D, Gobina R, Halle MP.   +7 more
europepmc   +1 more source